DNA Extraction from FFPE Tissues: Protocols and Quality Considerations

DNA extraction from formalin-fixed, paraffin-embedded (FFPE) tissues is a specialized method for recovering nucleic acids from archived clinical specimens that have been chemically crosslinked and embedded in paraffin wax. This protocol is essential when working with the vast repositories of FFPE tissues stored in pathology departments worldwide, enabling molecular analysis of samples collected over decades for research and clinical diagnostics. The method is particularly useful for retrospective studies, biomarker discovery, and molecular testing when fresh or frozen tissue is unavailable. Unlike DNA extraction from fresh tissues, FFPE protocols must address formalin-induced crosslinking, extensive DNA fragmentation, and paraffin removal, making it a technically demanding but indispensable technique in molecular pathology.

At a Glance

Scientific Principle

The fundamental challenge of FFPE DNA extraction lies in reversing the chemical modifications introduced during formalin fixation while recovering sufficient DNA for downstream applications. Formalin (formaldehyde solution) preserves tissue architecture by creating methylene crosslinks between proteins and nucleic acids, and between DNA strands themselves. These crosslinks must be reversed to release intact DNA molecules. Additionally, formalin fixation causes DNA fragmentation through hydrolysis and oxidation, with fragment sizes typically ranging from 100–500 base pairs [1].

The extraction process follows a sequential logic: first, paraffin must be removed to expose the tissue; second, protein crosslinks are digested with proteinase K under conditions that also promote crosslink reversal; third, DNA is purified from degraded proteins and other contaminants. The choice of deparaffinization method—organic solvent (xylene) versus aqueous-based alternatives—significantly impacts DNA yield and quality. Xylene effectively dissolves paraffin but requires subsequent ethanol washes and poses toxicity concerns, while commercial aqueous deparaffinization solutions offer safer handling but may be less efficient with heavily fixed tissues.

The duration of formalin fixation critically affects DNA quality. Extended fixation beyond 24–72 hours increases crosslinking density and fragmentation, reducing both yield and amplifiability. Studies have demonstrated that fixation time correlates with methylation degradation, supporting recommendations to limit formalin exposure to 3–4 days when possible [4]. This principle underlies the importance of knowing tissue fixation history when interpreting extraction outcomes.

Materials and Instrumentation Choices

Deparaffinization Options

Xylene-based method: Xylene (histological grade) is the traditional deparaffinization agent. It efficiently dissolves paraffin but requires multiple ethanol washes (100%, 95%, 70%) to remove residual xylene. Xylene is a hazardous solvent requiring fume hood use and proper waste disposal. This method provides consistent results across tissue types but adds processing time and chemical exposure risk.

Aqueous deparaffinization solutions: Commercial products (e.g., Deparaffinization Solution from Qiagen, Mineral Oil-based methods) use surfactants or oils to remove paraffin without organic solvents. These reduce toxicity concerns but may require longer incubation times or higher temperatures. Performance varies with tissue type and fixation history; heavily fixed or fatty tissues may show reduced efficiency.

Heat-based methods: Some protocols use heating at 60–70°C in mineral oil or buffer to melt paraffin without solvents. This approach is simpler but may not remove all paraffin, potentially inhibiting downstream enzymatic reactions.

Proteinase K Digestion

Proteinase K is the essential protease for digesting crosslinked proteins and releasing DNA. The enzyme concentration (typically 0.5–2 mg/mL), incubation temperature (56°C), and duration (1–24 hours) must be optimized. Longer digestion times (overnight) improve yield from heavily crosslinked samples but may increase DNA degradation. The digestion buffer typically contains Tris, EDTA, and SDS to denature proteins and chelate divalent cations that could activate nucleases.

Crosslink Reversal

Heat treatment at 90–98°C for 1–2 hours after proteinase K digestion is critical for reversing formalin crosslinks. This step must be carefully controlled: insufficient heating leaves crosslinks intact, reducing DNA availability; excessive heating causes further DNA fragmentation. Some protocols incorporate alkaline conditions (pH 8–9) to enhance reversal efficiency.

Purification Methods

Column-based purification: Silica membrane columns (e.g., QIAamp DNA FFPE Tissue Kit, DNeasy Blood & Tissue Kit) provide rapid purification with consistent quality. Binding buffers contain chaotropic salts and ethanol to promote DNA binding to silica. This method removes proteins, salts, and residual paraffin effectively but may shear large fragments.

Magnetic bead purification: Paramagnetic beads (e.g., AMPure XP, SPRIselect) offer size-selective purification, allowing removal of very small fragments (<100 bp) that may interfere with downstream applications. This method is gentler on DNA and scalable for automation but requires careful bead-to-sample ratio optimization.

Organic extraction: Phenol-chloroform extraction followed by ethanol precipitation provides high yields but requires hazardous chemicals and multiple tube transfers, increasing contamination risk. This method is rarely used in clinical settings but may be preferred for research applications requiring maximum DNA recovery.

Instrumentation

• Microcentrifuge (14,000–20,000 × g)
• Heating block or thermomixer (56°C and 90°C capability)
• Vortex mixer
• Fume hood (for xylene-based methods)
• Spectrophotometer (NanoDrop or similar) for concentration and purity assessment
• Qubit fluorometer for accurate dsDNA quantification
• Thermal cycler for quality control PCR

Controls

Appropriate controls are essential for validating FFPE DNA extraction quality and troubleshooting failed preparations.

Positive extraction control: A well-characterized FFPE tissue block with known DNA yield and amplifiability should be processed alongside experimental samples. This control verifies that reagents and protocol steps are functioning correctly.

Negative extraction control: Process a blank paraffin block or empty tube through the entire extraction procedure. This control detects reagent contamination with exogenous DNA.

No-template control (NTC): Include in PCR-based quality assessments to rule out amplicon contamination.

Amplification control: A housekeeping gene PCR (e.g., GAPDH, β-actin) with primers designed to amplify short (100–200 bp) and long (300–400 bp) fragments provides information on DNA integrity and amplifiability. Successful amplification of the short fragment with failure of the long fragment indicates significant fragmentation.

Inhibition control: Spike a known quantity of control DNA into a sample aliquot before PCR. Reduced amplification compared to the control alone indicates the presence of PCR inhibitors in the DNA preparation.

Conceptual Workflow

Step 1: Tissue Section Preparation

Cut 5–10 µm sections from the FFPE block using a microtome. For DNA extraction, 1–4 sections are typically sufficient, depending on tissue area and cellularity. Use a fresh microtome blade for each block to prevent cross-contamination. Place sections in a 1.5–2 mL microcentrifuge tube. If using stained slides (e.g., H&E-stained sections for tumor enrichment), scrape the marked region with a sterile scalpel and transfer to a tube [4].

Step 2: Deparaffinization

Xylene method: Add 1 mL xylene, vortex vigorously, incubate at 50–60°C for 5–10 minutes, then centrifuge at full speed for 2 minutes. Remove supernatant carefully. Repeat xylene wash once. Add 1 mL 100% ethanol, vortex, centrifuge, and remove supernatant. Repeat with 95% ethanol, then 70% ethanol. Air-dry the pellet for 5–10 minutes at room temperature.

Aqueous method: Add commercial deparaffinization solution according to manufacturer instructions. Typically, incubate at 56°C for 10–30 minutes with occasional vortexing, then centrifuge and remove the paraffin-containing layer.

Step 3: Proteinase K Digestion

Add 180–200 µL of digestion buffer (containing Tris, EDTA, SDS) and 20 µL proteinase K (20 mg/mL stock). Vortex to resuspend the pellet. Incubate at 56°C with shaking (300–900 rpm) for 1–24 hours. For heavily fixed tissues, overnight digestion (16–18 hours) improves yield. Add additional proteinase K (10–20 µL) after 4–6 hours if tissue remains undigested.

Step 4: Crosslink Reversal

After digestion, heat the sample at 90°C for 1–2 hours. This step is critical for reversing formalin crosslinks and must be performed in a sealed tube to prevent evaporation. Some protocols include a brief centrifugation to collect condensation before proceeding.

Step 5: DNA Purification

Column method: Add binding buffer (containing chaotropic salts and ethanol) according to manufacturer ratios. Mix thoroughly, transfer to a silica membrane column, centrifuge, wash with ethanol-based buffers, and elute in 30–100 µL of low-salt buffer (e.g., TE or nuclease-free water).

Magnetic bead method: Add beads at appropriate ratio (typically 1.8× sample volume for DNA >100 bp), mix, incubate at room temperature for 5–15 minutes, place on magnetic rack, wash with 70% ethanol, air-dry, and elute in 20–50 µL buffer.

Step 6: DNA Quantification and Quality Assessment

Measure DNA concentration using fluorometric methods (Qubit) for accurate dsDNA quantification. Spectrophotometric measurement (NanoDrop) provides A260/A280 and A260/A230 ratios but may overestimate concentration due to RNA or degraded DNA contamination. Assess DNA integrity by agarose gel electrophoresis or Bioanalyzer; FFPE DNA typically appears as a smear from 100–500 bp.

Quality Checks

Purity Assessment

A260/A280 ratio: Values between 1.8–2.0 indicate pure DNA. Lower values suggest protein or phenol contamination; higher values may indicate RNA contamination. Note that FFPE DNA preparations often show slightly lower ratios (1.7–1.9) due to residual crosslinked material.

A260/A230 ratio: Values >1.8 indicate minimal contamination with chaotropic salts, ethanol, or carbohydrates. Lower values suggest residual purification reagents that may inhibit downstream enzymatic reactions.

DNA Integrity Assessment

Gel electrophoresis: Run 50–100 ng of DNA on a 1.5–2% agarose gel. FFPE DNA appears as a smear with most fragments between 100–500 bp. Absence of visible DNA suggests degradation or low yield; a high molecular weight band suggests incomplete deparaffinization or crosslink reversal.

Bioanalyzer or TapeStation: Provides precise fragment size distribution and DNA integrity number (DIN). FFPE samples typically have DIN values of 2–5 (scale 1–10), with higher values indicating better preservation.

Amplifiability Testing

Perform a multiplex PCR with primers targeting short (100–150 bp), medium (200–300 bp), and long (400–500 bp) amplicons. Successful amplification of the short fragment confirms DNA is present and amplifiable. Failure of longer fragments indicates extensive fragmentation, limiting suitability for applications requiring larger templates.

Result Interpretation

Successful FFPE DNA extraction yields sufficient amplifiable DNA for downstream applications, but interpretation must account for the inherent limitations of the starting material.

Yield expectations: Typical yields range from 0.1–10 µg per 10 µm section, depending on tissue cellularity, fixation history, and extraction efficiency. Low yields (<0.1 µg) may indicate poor tissue preservation, incomplete digestion, or excessive fragmentation. High yields (>10 µg) may include significant RNA contamination if RNase treatment was not included.

Fragment size distribution: Most FFPE DNA fragments fall between 100–500 bp. Samples with fragments predominantly <150 bp may fail in applications requiring longer templates (e.g., certain NGS library preparation methods). Samples with fragments >500 bp are unusual and may indicate incomplete crosslink reversal or contamination with genomic DNA from fresh tissue.

Amplifiability: Successful amplification of a 100–200 bp target indicates DNA is suitable for most PCR-based applications. Failure to amplify even short targets suggests either insufficient DNA, presence of PCR inhibitors, or extensive crosslinking that was not reversed. The inhibition control helps distinguish between these possibilities.

Methylation analysis considerations: FFPE processing causes modest methylation loss, with degradation correlating with fixation time [4]. For methylation studies, samples fixed for ≤3–4 days are preferred. Longer fixation may lead to underestimation of methylation levels.

Troubleshooting

Limitations

FFPE DNA extraction has inherent limitations that must be considered when designing experiments and interpreting results.

DNA fragmentation: The average fragment size of FFPE DNA (100–500 bp) limits applications requiring long contiguous sequences. Whole-genome sequencing, long-range PCR, and certain structural variant analyses may be impractical. This fragmentation is an unavoidable consequence of formalin fixation and cannot be fully reversed [1].

Sequence artifacts: Formalin fixation can cause deamination of cytosine to uracil, leading to C→T transitions in sequencing data. This artifact is particularly problematic for mutation detection at low allele frequencies. Uracil-DNA glycosylase (UDG) treatment can reduce these artifacts but may also reduce overall DNA yield.

Variable quality across samples: FFPE blocks from different institutions, fixation protocols, and storage conditions show substantial variability in DNA quality. Even within a single block, tissue heterogeneity can affect extraction efficiency. This variability complicates experimental design and may require sample-specific optimization.

Low yield from small samples: Microdissected samples, needle biopsies, or sections with low cellularity may yield insufficient DNA for multiple downstream applications. The minimum input for some NGS protocols is 10–50 ng, which may be challenging to obtain from small FFPE samples [4].

Incompatibility with certain applications: FFPE DNA is generally unsuitable for applications requiring high molecular weight DNA, such as optical mapping, long-read sequencing without specialized protocols, or certain epigenetic assays that require intact DNA.

Chemical contamination: Residual formalin, paraffin, or xylene can inhibit downstream enzymatic reactions. Even with careful purification, some samples may require additional cleanup or the use of PCR additives.

Documentation

Proper documentation of FFPE DNA extraction is essential for reproducibility and quality assurance in both research and clinical settings.

Sample metadata: Record tissue type, fixation method (e.g., 10% neutral buffered formalin), fixation duration, block age, storage conditions, and any prior processing (e.g., decalcification, special stains). This information is critical for interpreting DNA quality and yield.

Extraction protocol details: Document the specific kit or method used, lot numbers of critical reagents (proteinase K, columns, beads), incubation times and temperatures, and any deviations from the standard protocol.

Quality metrics: Record DNA concentration (from both spectrophotometer and fluorometer), A260/A280 and A260/A230 ratios, fragment size distribution (gel image or Bioanalyzer trace), and amplification results from quality control PCR.

Downstream application requirements: Note the specific requirements of the intended downstream application (e.g., minimum input amount, required fragment size) and whether the extracted DNA meets these criteria.

Storage conditions: Store DNA at -20°C for short-term use or -80°C for long-term storage. Avoid repeated freeze-thaw cycles by aliquoting. Document storage location and date.

Biosafety Considerations

FFPE tissue processing is classified as BSL-1 routine work, as formalin fixation inactivates most infectious agents. However, appropriate safety precautions must be observed [6].

Chemical hazards: Xylene is a flammable, toxic solvent requiring use in a chemical fume hood. Ethanol is flammable. Formalin residues in tissue may be present; avoid inhalation of dust when cutting sections. Use appropriate personal protective equipment (lab coat, gloves, safety glasses).

Biological hazards: While fixation reduces infectivity, FFPE tissues may still contain residual viable organisms, particularly if fixation was inadequate. Treat all human tissue samples as potentially infectious. Follow standard precautions for handling human specimens [6].

Waste disposal: Xylene and xylene-containing waste must be collected in designated hazardous waste containers. Ethanol waste should be disposed of according to institutional guidelines. Tissue residues and contaminated consumables should be treated as biohazardous waste.

Sharps safety: Use caution when handling microtome blades and scalpel blades for tissue scraping. Dispose of sharps in approved puncture-resistant containers.

Recombinant DNA considerations: If extracted DNA will be used in experiments involving recombinant or synthetic nucleic acid molecules, follow NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [7].

Frequently Asked Questions

1. Can I use FFPE DNA for whole-genome sequencing? FFPE DNA is generally not suitable for standard whole-genome sequencing due to extensive fragmentation (typically 100–500 bp). However, specialized library preparation methods designed for degraded DNA can enable targeted sequencing, exome sequencing, or reduced-representation approaches. Some nanopore sequencing protocols have been adapted for FFPE DNA, though coverage and accuracy may be reduced compared to fresh-frozen samples [4].

2. How long can FFPE blocks be stored before DNA extraction becomes unreliable? DNA can be successfully extracted from FFPE blocks stored for decades, but quality generally decreases with storage time. Blocks stored for less than 5 years typically yield the best DNA. Factors affecting long-term stability include fixation quality, storage temperature (cool, dry conditions preferred), and exposure to light or humidity. Older blocks may require longer proteinase K digestion and may yield more fragmented DNA.

3. Why does my FFPE DNA have a low A260/A230 ratio even after purification? Low A260/A230 ratios (below 1.5) typically indicate contamination with chaotropic salts from column-based purification or residual organic compounds from the tissue. This is common with FFPE samples and does not necessarily indicate poor DNA quality. If downstream applications (PCR, NGS) are successful, the low ratio can be tolerated. If inhibition occurs, repeat purification using magnetic bead cleanup or ethanol precipitation can improve the ratio.

4. Can I use the same FFPE DNA extraction protocol for all tissue types? No, different tissue types require protocol optimization. Fatty tissues (breast, brain, adipose) may require additional deparaffinization steps or longer digestion. Decalcified bone samples may have additional DNA damage from acid treatment. Tissues with high connective tissue content (skin, tendon) may need extended proteinase K digestion. It is recommended to test the protocol on a representative sample before processing valuable specimens.

References and Further Reading

1. Korodimos N, Tomos I, Foukas P, et al. Challenges and Limitations in Molecular Testing of Resected Non-Small Cell Lung Cancer Specimens. (2026). https://pubmed.ncbi.nlm.nih.gov/42042079/ — Discusses FFPE sample limitations in molecular testing, including tissue quality and DNA fragmentation considerations.

2. AlHammadi SA, Nagshabandi LN, Muhammad H, et al. Mass spectrometry-based proteomics of FFPE tissues: progress, limitations, and clinical translation barriers. (2025). https://pubmed.ncbi.nlm.nih.gov/41315957/ — Reviews technical barriers in FFPE sample analysis, including standardization challenges relevant to DNA extraction.

3. Andersen V, Liebeke M, Reinisch W, et al. Potential of Clinical Care-Collected Gut Biopsies for Advancing Personalised Medicine in Inflammatory Bowel Disease. (2026). https://pubmed.ncbi.nlm.nih.gov/42239996/ — Discusses FFPE biopsy handling and the need for standardized protocols to improve molecular analysis quality.

4. Feinberg-Gorenshtein G, Grunwald A, Vermeulen C, et al. Brain tumor classification from FFPE samples using nanopore methylation sequencing. (2025). https://pubmed.ncbi.nlm.nih.gov/41180011/ — Provides validated protocol for FFPE DNA extraction and demonstrates correlation between fixation time and methylation degradation.

5. Burlakoti RR, Sapkota S, Burlakoti P, et al. MinION Nanopore-Enabled Identification and Genomic Characterization of Pseudomonas syringae Complex Infecting Blueberry. (2026). https://pubmed.ncbi.nlm.nih.gov/41738530/ — Describes DNA extraction and quality control protocols applicable to FFPE-like degraded samples.

6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. (2020). https://www.cdc.gov/labs/bmbl/index.html — Authoritative biosafety guidelines for laboratory work with human tissues and chemicals.

7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/ — Regulatory framework for recombinant DNA work using extracted nucleic acids.

8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. https://www.ncbi.nlm.nih.gov/books/ — Searchable collection of molecular biology protocols and reference materials.

Related Articles

• RNA Extraction from FFPE Tissues: Challenges and Protocols
• Genomic DNA Extraction from Blood: Protocols and Quality Assessment
• DNA Extraction from Soil: Protocols for Environmental Samples
• DNA Extraction from Plant Tissues: CTAB and Kit-Based Methods
• DNA Extraction from Yeast: Protocols for Genomic and Plasmid DNA
• DNA Extraction from Mouse Tail Biopsies: Protocol for Genotyping